| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ondansetron | FAERS: 4 | US FAERS | |
| 2 | Rivastigmine | FAERS: 4 | US FAERS | |
| 3 | Lisdexamfetamine Dimesylate | FAERS: 3 | US FAERS | |
| 4 | Teriparatide | FAERS: 3 | US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 6 | deflazacort | FAERS: 2 | US FAERS | |
| 7 | Anidulafungin | FAERS: 1 | US FAERS | |
| 8 | Aripiprazole | FAERS: 1 | US FAERS | |
| 9 | Buspirone | FAERS: 1 | US FAERS | |
| 10 | Capecitabine | FAERS: 1 | US FAERS | |
| 11 | Clozapine | FAERS: 1 | OFFSIDES US FAERS | |
| 12 | Diovan Hct | FAERS: 1 | US FAERS | |
| 13 | Droxidopa | FAERS: 1 | US FAERS | |
| 14 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 15 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 16 | Everolimus | FAERS: 1 | US FAERS | |
| 17 | LCZ 696 | FAERS: 1 | US FAERS | |
| 18 | Methylphenidate | FAERS: 1 | US FAERS | |
| 19 | Methylphenidate | FAERS: 1 | US FAERS | |
| 20 | Naltrexone | FAERS: 1 | US FAERS | |
| 21 | Primidone | FAERS: 1 | OFFSIDES US FAERS | |
| 22 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 23 | Tetrabenazine | FAERS: 1 | US FAERS | |
| 24 | Varenicline | FAERS: 1 | US FAERS | |
| 25 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 26 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 27 | aripiprazole lauroxil | FAERS: 1 | US FAERS | |
| 28 | lenvatinib | FAERS: 1 | US FAERS | |
| 29 | montelukast | FAERS: 1 | US FAERS | |
| 30 | pazopanib | FAERS: 1 | US FAERS | |
| 31 | pimavanserin | FAERS: 1 | US FAERS | |
| 32 | Carbimazole | OFFSIDES | ||
| 33 | Hydron;carbonate | OFFSIDES | ||
| 34 | Pramipexole | OFFSIDES | ||
| 35 | Sulpiride | OFFSIDES | ||
| 36 | Terbinafine | OFFSIDES | ||
| 37 | Triazolam | OFFSIDES | ||
| 38 | ropinirole | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.